Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing

The investigation is designed as an open, non-controlled, post-marketing clinical follow-up. Subjects with chronic ulcers or partial thickness burns (including donor sites) at 2 sites will be included. Each subject with a chronic ulcer will be seen once a week for a maximum of 4 weeks or until desired treatment effect is obtained, whichever occurs earlier. Each subject with a partial thickness burn/donor site will be followed once a week for a maximum of 3 weeks or until desired treatment effect is obtained, whichever occurs earlier. All dressing changes will be done according to clinical routine practices and will follow IFU (instruction for use)

Inclusion criteria

• Subject with a chronic ulcer (venous leg, diabetic foot and pressure ulcers) or a partial thickness burn where an antimicrobial action is indicated* as judged by the investigator
• Male or female, 18 years and above, both in- and out-patients
• Signed Informed Consent Form

Exclusion criteria

• Wound size equal to or above 9.5x15cm for the wound/burn to be included in the investigation
• Subject not expected to follow the investigation procedures
• TBSA > 10% (partial thickness burns only)
• HbA1C value > 7.2. (To be measured if BMI > 30)
• Pregnant and breastfeeding women
• Pressure ulcers deeper than stage 3
• Deep pressure ulcers in need of a filler
• Subjects with known sensitivity to silver or any other dressing materials
• Subjects receiving radiation treatment or examinations e.g. X-ray, ultrasound, diathermy or Magnetic Resonance Imaging
• Subjects using oxidising agents such as hypochlorite solutions or hydrogen peroxide
• Subjects previously included in this investigation
• Subjects included in other ongoing clinical investigation at present or during the past 30 days